116 related articles for article (PubMed ID: 15666307)
1. Isolated elevated sweat chloride concentrations in the presence of the rare mutation S1455X: an extremely mild form of CFTR dysfunction.
Salvatore D; Tomaiuolo R; Vanacore B; Elce A; Castaldo G; Salvatore F
Am J Med Genet A; 2005 Mar; 133A(2):207-8. PubMed ID: 15666307
[TBL] [Abstract][Full Text] [Related]
2. A mutation in the cystic fibrosis transmembrane conductance regulator gene associated with elevated sweat chloride concentrations in the absence of cystic fibrosis.
Mickle JE; Macek M; Fulmer-Smentek SB; Egan MM; Schwiebert E; Guggino W; Moss R; Cutting GR
Hum Mol Genet; 1998 Apr; 7(4):729-35. PubMed ID: 9499426
[TBL] [Abstract][Full Text] [Related]
3. Role of CFTR mutation analysis in the diagnostic algorithm for cystic fibrosis.
Ratkiewicz M; Pastore M; McCoy KS; Thompson R; Hayes D; Sheikh SI
World J Pediatr; 2017 Apr; 13(2):129-135. PubMed ID: 28194692
[TBL] [Abstract][Full Text] [Related]
4. Variant cystic fibrosis phenotypes in the absence of CFTR mutations.
Groman JD; Meyer ME; Wilmott RW; Zeitlin PL; Cutting GR
N Engl J Med; 2002 Aug; 347(6):401-7. PubMed ID: 12167682
[TBL] [Abstract][Full Text] [Related]
5. Mild cystic fibrosis revealed by persistent hyponatremia during the French 2003 heat wave, associated with the S1455X C-terminus CFTR mutation.
Epaud R; Girodon E; Corvol H; Niel F; Guigonis V; Clement A; Feldmann D; Bensman A; Ulinski T
Clin Genet; 2005 Dec; 68(6):552-3. PubMed ID: 16283887
[No Abstract] [Full Text] [Related]
6. CFTR genotypes in patients with normal or borderline sweat chloride levels.
Feldmann D; Couderc R; Audrezet MP; Ferec C; Bienvenu T; Desgeorges M; Claustres M; Mittre H; Blayau M; Bozon D; Malinge MC; Monnier N; Bonnefont JP; Iron A; Bieth E; Dumur V; Clavel C; Cazeneuve C; Girodon E
Hum Mutat; 2003 Oct; 22(4):340. PubMed ID: 12955726
[TBL] [Abstract][Full Text] [Related]
7. CFTR genotype and clinical outcomes of adult patients carried as cystic fibrosis disease.
Bonadia LC; de Lima Marson FA; Ribeiro JD; Paschoal IA; Pereira MC; Ribeiro AF; Bertuzzo CS
Gene; 2014 May; 540(2):183-90. PubMed ID: 24583165
[TBL] [Abstract][Full Text] [Related]
8. Correlation of sweat chloride concentration with classes of the cystic fibrosis transmembrane conductance regulator gene mutations.
Wilschanski M; Zielenski J; Markiewicz D; Tsui LC; Corey M; Levison H; Durie PR
J Pediatr; 1995 Nov; 127(5):705-10. PubMed ID: 7472820
[TBL] [Abstract][Full Text] [Related]
9. Normal sweat chloride test does not rule out cystic fibrosis.
Başaran AE; Karataş-Torun N; Maslak İC; Bingöl A; Alper ÖM
Turk J Pediatr; 2017; 59(1):68-70. PubMed ID: 29168366
[TBL] [Abstract][Full Text] [Related]
10. In vitro prediction of stop-codon suppression by intravenous gentamicin in patients with cystic fibrosis: a pilot study.
Sermet-Gaudelus I; Renouil M; Fajac A; Bidou L; Parbaille B; Pierrot S; Davy N; Bismuth E; Reinert P; Lenoir G; Lesure JF; Rousset JP; Edelman A
BMC Med; 2007 Mar; 5():5. PubMed ID: 17394637
[TBL] [Abstract][Full Text] [Related]
11. Refining the continuum of CFTR-associated disorders in the era of newborn screening.
Levy H; Nugent M; Schneck K; Stachiw-Hietpas D; Laxova A; Lakser O; Rock M; Dahmer MK; Biller J; Nasr SZ; Baker M; McColley SA; Simpson P; Farrell PM
Clin Genet; 2016 May; 89(5):539-49. PubMed ID: 26671754
[TBL] [Abstract][Full Text] [Related]
12. Sweat chloride and immunoreactive trypsinogen in infants carrying two
Castellani C; Tridello G; Tamanini A; Assael BM
Arch Dis Child; 2017 Jul; 102(7):644-646. PubMed ID: 26755536
[TBL] [Abstract][Full Text] [Related]
13. Diversity of the basic defect of homozygous CFTR mutation genotypes in humans.
Stanke F; Ballmann M; Bronsveld I; Dörk T; Gallati S; Laabs U; Derichs N; Ritzka M; Posselt HG; Harms HK; Griese M; Blau H; Mastella G; Bijman J; Veeze H; Tümmler B
J Med Genet; 2008 Jan; 45(1):47-54. PubMed ID: 18178635
[TBL] [Abstract][Full Text] [Related]
14. Association of sweat chloride concentration at time of diagnosis and CFTR genotype with mortality and cystic fibrosis phenotype.
McKone EF; Velentgas P; Swenson AJ; Goss CH
J Cyst Fibros; 2015 Sep; 14(5):580-6. PubMed ID: 25660278
[TBL] [Abstract][Full Text] [Related]
15. Mutations of the cystic fibrosis gene and intermediate sweat chloride levels in children.
Lebecque P; Leal T; De Boeck C; Jaspers M; Cuppens H; Cassiman JJ
Am J Respir Crit Care Med; 2002 Mar; 165(6):757-61. PubMed ID: 11897640
[TBL] [Abstract][Full Text] [Related]
16. Phenotypic characterisation of patients with intermediate sweat chloride values: towards validation of the European diagnostic algorithm for cystic fibrosis.
Goubau C; Wilschanski M; Skalická V; Lebecque P; Southern KW; Sermet I; Munck A; Derichs N; Middleton PG; Hjelte L; Padoan R; Vasar M; De Boeck K
Thorax; 2009 Aug; 64(8):683-91. PubMed ID: 19318346
[TBL] [Abstract][Full Text] [Related]
17. Cystic fibrosis transmembrane conductance regulator channel dysfunction in non-cystic fibrosis bronchiectasis.
Bienvenu T; Sermet-Gaudelus I; Burgel PR; Hubert D; Crestani B; Bassinet L; Dusser D; Fajac I
Am J Respir Crit Care Med; 2010 May; 181(10):1078-84. PubMed ID: 20167849
[TBL] [Abstract][Full Text] [Related]
18. Two novel missense and one novel nonsense CFTR mutations in Iranian males with congenital bilateral absence of the vas deferens.
Radpour R; Gourabi H; Gilani MA; Dizaj AV; Rezaee M; Mollamohamadi S
Mol Hum Reprod; 2006 Nov; 12(11):717-21. PubMed ID: 16973827
[TBL] [Abstract][Full Text] [Related]
19. Correlation of sweat chloride concentration with genotypes in cystic fibrosis patients in Saguenay Lac-Saint-Jean, Quebec, Canada.
De Braekeleer M; Allard C; Leblanc JP; Aubin G; Simard F
Clin Biochem; 1998 Feb; 31(1):33-6. PubMed ID: 9559222
[TBL] [Abstract][Full Text] [Related]
20. Negative sweat test in hypertrypsinaemic infants with cystic fibrosis carrying rare CFTR mutations.
Padoan R; Bassotti A; Seia M; Corbetta C
Eur J Pediatr; 2002 Apr; 161(4):212-5. PubMed ID: 12014388
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
